Saturday, August 23, 2008

Day +780 : Cancer is Not a Death Sentence (3)

I am fine today. Continue from yesterday…

A Leukaemia friend in UH told me a story about a product called Transfer Factor. If I were not mistaken, the product is sold by a multi-level company called 4Life. An agent from the company visited me and introduced to me the product while I was doing chemotherapy in UH. He was quite professional as he didn’t try to convince me that the product could work as a magic cure.

The Leukaemia friend told me that a patient from Sabah was receiving treatment in UH hematology in August 2006. His condition improved amazingly after taking Transfer Factor. Many patients in the ward were very excited about this at that time. And many of them started to take the product. However, no one was cured and the patient from Sabah passed away in December in the same year. But a very “powerful” testimony which described the situation in August 2006 might be used to make people believe that the product cures Leukaemia or cancers.

In order to prove that an approach or product works, a proper clinical trial must be done and the result published in an authoritative journal. Since a paper has to go through a stringent peer review process before it is accepted for publication, the likeliness of fraud or manipulation of trial result is significantly reduced. The author of the paper is subjected to legal action if he/she was found to fabricate research findings.

One example of well known research fraud was related to a South Korea stem-cell scientist, Professor Hwang Woo-Suk, who published the results of his research in two papers in the scientific journal Nature with fabricated result. What happened to him?

On May 12, 2006, Hwang was "indicted on embezzlement and bioethics law violations linked to faked stem cell research." Korea Times reported on June 10, 2007 that "The university expelled him and the government rescinded its financial and legal support. [Wikipedia]

He could spend as much as ten years in jail if convicted.

To be continued and see you next post :-)

No comments: